Seattle Genetics, Inc.

NASDAQ: SGEN
$228.74
+$0.00 (+0.0%)
Closing Price on January 9, 2024

SGEN Articles

After a very long run in the market from the 2009 lows, there is always the chance a healthy correction is right around the corner. Here are six stocks that Cantor Fitzgerald analysts say investors...
In a week that saw the markets continue to march higher, some of the top Wall Street firms that we cover were lowering the boom with Sell ratings on some very high profile names.
Source: courtesy Deere & Co.Despite the fact that the market has enjoyed a nice bounce from the January sell-off, we are noticing that more and more Sell ratings are starting to hit our daily...
Source: ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive on large cap biotechnology names. Acknowledging in...
Source: ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) that was rejected. The...
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, June 4, 2013. They include FedEx, GE, Ulta Salon and Walmart.
These are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Monday. Air Products & Chemicals Inc. (NYSE: APD) raised to Buy at Goldman Sachs. Berry...
We have many stocks moving this morning. 24/7 Wall St. has tracked moves in shares of the following: Concur Technologies Inc. (NASDAQ: CNQR), DUSA Pharmaceuticals Inc. (NASDAQ: DUSA), Genomic Health...
Source: Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Friday.Advance Auto Parts Inc. (NYSE: AAP) named Bear of the Day at...
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take...
It is now getting close to the middle of May, and that means one thing for biotech investors.  The king of biotech and pharma events is about to take place.  The 2012 annual meeting of the American...
Markets opened lower this morning, and a modest gain of 80,000 non-farm jobs and a slight improvement of the US unemployment rate to 9.0% didn’t lift investors’ spirits before the opening....
Each morning we review our top upgrades, downgrades, and initiations from Wall Street analysts.  At the end of the week, we review these more closely along with other calls made throughout the week...
There is an old rule of thumb from biotech investors and traders… SELL FDA APPROVALS.  This is very counter-intuitive on the surface but we wanted to explain in more detail why this is the case...
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday morning.Agrium Inc. (NYSE: AGU) Cut to Underperform at BofA/ML. Intrepid...